NI
MRNS

Numeric Investors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Numeric Investors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,907
Closed -$197K – 1153
2015
Q3 		$197K Buy
+5,907
New +$333K ﹤0.01% 933

Other funds holding MRNS

CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Numeric Investors's MRNS Position: Q4 2015 in Review

Numeric Investors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2015, closing a stake of 5,907 shares — an estimated $197K sold.

Numeric Investors first reported a position in MRNS in Q3 2015 and held it in 1 quarter. The position peaked at $197K in Q3 2015. 38 funds tracked by Wall St. Rank hold MRNS as of Q4 2015.

  • Numeric Investors reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2015 after selling out during the quarter.
  • Numeric Investors sold 5,907 Marinus Pharmaceuticals, Inc shares in Q4 2015, an estimated $197K.
  • Numeric Investors first reported a position in Marinus Pharmaceuticals, Inc in Q3 2015 and held it in 1 quarter.
  • Numeric Investors's Marinus Pharmaceuticals, Inc position peaked at $197K in Q3 2015.
  • 38 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2015.

Based on Numeric Investors's 13F filing for Q4 2015, filed 1 Feb 2016.